Carisma Therapeutics is developing a unique, differentiated immuno-oncology (IO) treatment for solid tumors based on chimeric antigen receptor macrophages (CAR-M). Current IO treatments have ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

We’ve seen some lesions shrink after a single dose of CAR macrophages.” And while their research has focused on patients with ...

Researchers at the University of Basel have developed CAR T-cells that target glioblastoma, a notoriously aggressive brain ...

In her talk she described programming macrophages to eat cancer cells as a novel treatment for the disease, an approach called CAR-M. Morrissey had found that adding a CAR receptor to macrophages ...

Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...

近日，良渚实验室 张进团队与中国科学院动物研究所 宋默识研究组合作，在Circulation Research杂志在线发表了题为 “CAR-macrophage therapy alleviates myocardial ...